期刊
MOLECULAR ASPECTS OF MEDICINE
卷 30, 期 1-2, 页码 86-98出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.mam.2008.08.009
关键词
Glutamate cysteine ligase; GCL; GCLC; GCLM; Glutathione; GSH; Post-translational
资金
- NIH [R01ES10849, P01AG01751, P42ES04696, P30ES07033, T32ES07032, R01CA90473, RO1ES05511]
Glutathione (GSH) is a tripeptide composed of glutamate, cysteine, and glycine. The first and rate-limiting step in GSH synthesis is catalyzed by glutamate cysteine ligase (GCL, previously known as gamma-glutamylcysteine synthetase). GCL is a heterodimeric protein composed of catalytic (GCLC) and modifier (GCLM) subunits that are expressed from different genes. GCLC catalyzes a unique gamma-carboxyl linkage from glutamate to cysteine and requires ATP and Mg++ as cofactors in this reaction. GCLM increases the V-max and K-cat of GCLC. decreases the K-m for glutamate and ATP, and increases the K-i for GSH-mediated feedback inhibition of GCL While post-translational modifications of GCLC (e.g. phosphorylation, myristoylation, caspase-mediated cleavage) have modest effects on GCL activity, oxidative stress dramatically affects GCL holoenzyme formation and activity. Pyridine nucleotides can also modulate GCL activity in some species. Variability in GCL expression is associated with several disease phenotypes and transgenic mouse and rat models promise to be highly useful for investigating the relationships between GCL activity, GSH synthesis, and disease in humans. (C) 2008 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据